Olema Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:OLMA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Aug 24	SellUS$35,796,000	Paradigm Biocapital Advisors LP	Company	2,400,000	US$14.92
04 Jun 24	SellUS$17,448,750	Logos Global Management, L.P.	Company	1,175,000	US$14.85
06 Dec 23	BuyUS$1,160,000	Paradigm Biocapital Advisors LP	Company	100,000	US$11.60
05 Dec 23	BuyUS$1,871,280	Logos Global Management, L.P.	Company	131,870	US$14.95

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.8%.

Top 25 shareholders own 92.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16%	BVF Partners L.P.	9,135,893	US$92.5m	0%	2.33%
9.61%	Paradigm Biocapital Advisors LP	5,503,600	US$55.7m	-30.4%	1.69%
6.99%	Deep Track Capital, LP	4,000,000	US$40.5m	0%	1.05%
6.72%	BlackRock, Inc.	3,847,471	US$38.9m	-3.8%	no data
6.44%	Point72 Asset Management, L.P.	3,687,374	US$37.3m	14.3%	0.08%
5.6%	Logos Global Management, L.P.	3,208,875	US$32.5m	0%	3.3%
4.68%	BioImpact Capital LLC	2,680,596	US$27.1m	0.97%	3.71%
4.42%	The Vanguard Group, Inc.	2,532,892	US$25.6m	-7.65%	no data
3.44%	State Street Global Advisors, Inc.	1,969,963	US$19.9m	1.13%	no data
2.91%	Pictet Asset Management Limited	1,667,459	US$16.9m	0%	0.01%
2.63%	Candriam, Société En Commandite Par Actions	1,506,764	US$15.2m	42.3%	0.04%
2.63%	Vivo Capital, LLC	1,505,862	US$15.2m	-19.6%	1.06%
2.4%	Dimensional Fund Advisors LP	1,376,924	US$13.9m	-18.3%	no data
2.37%	Woodline Partners LP	1,354,186	US$13.7m	58.8%	0.1%
2.19%	Citadel Advisors LLC	1,252,745	US$12.7m	847%	0.01%
1.75%	Wellington Management Group LLP	1,002,685	US$10.1m	10.8%	no data
1.75%	Great Point Partners, LLC	1,000,000	US$10.1m	25.5%	3.12%
1.63%	Geode Capital Management, LLC	934,929	US$9.5m	-11.8%	no data
1.53%	Cyrus Harmon	873,311	US$8.8m	-1.13%	no data
1.49%	Victory Capital Management Inc.	851,512	US$8.6m	9.9%	0.01%
1.3%	David Myles	741,776	US$7.5m	0%	no data
1.24%	Balyasny Asset Management L.P.	709,097	US$7.2m	0%	0.02%
1.14%	Tavistock Life Sciences	650,000	US$6.6m	0%	0.36%
0.93%	Ghost Tree Capital, LLC	535,000	US$5.4m	-2.73%	1.71%
0.89%	Shane William Kovacs	510,458	US$5.2m	5.25%	no data